(Q56536196)

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Structure of the human histamine H1 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

G-protein signaling: back to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Mutational analysis of the antagonist-binding site of the histamine H(1) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

The role of histamine and the tuberomamillary nucleus in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

The physiology of brain histamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Advances in H1-antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Clinical outcomes and adverse effect monitoring in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

The hypnotic effects of an antihistamine: promethazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

The H1 histamine receptor blocker, chlorpheniramine, completely prevents the increase in REM sleep induced by immobilization stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Boxed warning added to promethazine labeling for pediatric use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Endogenous airway acidification. Implications for asthma pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Changes in pH differently affect the binding properties of histamine H1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Twenty-four hours of activity of cetirizine and fexofenadine in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Clinical pharmacokinetics of fexofenadine enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Capsaicin for allergic rhinitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

P-Glycoprotein, a gatekeeper in the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Dose dependency of brain histamine H(1) receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Loratadine versus cetirizine: assessment of somnolence and motivation during the workday

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Non-interventional study comparing treatment satisfaction in patients treated with antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Cardiac actions of antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

H(1) antihistamine drug promethazine directly blocks hERG K(+) channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Electrocardiographic findings in patients with diphenhydramine overdose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Safety of antihistamines in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Second-generation antihistamines: the risk of ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Comparative pharmacology of H1 antihistamines: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22

Clinical pharmacology of H1-antihistamines in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1939-4551-4-S3-S22